Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Predictmedix AI Inc C.PMED

Alternate Symbol(s):  PMEDF

Predictmedix AI Inc. is a life sciences technology company. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. It has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. It is also developing AI-powered products that address detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. It is adding additional modules to this Mobile Wellbeing platform that enable us to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.


CSE:PMED - Post by User

Bullboard Posts
Post by tor27on Apr 23, 2020 10:39am
354 Views
Post# 30944347

PMED Est. Revenue Forecast

PMED Est. Revenue Forecast
Checking the liability rates in North America and India on a per employee and impaired basis.  That is associated loss per employee due to impairment.  Not per impaired employee....per average employee in the entire work force.  So you can imagine individual claims or industrial accidents must be quite high.
 
* North America the typical cost is $7k USD per employee. 
 
* In India the typical cost is $2 to $3k USD per emplyee.
 
So Hindalco has 36,000 employees and let's take a blended average of $4k per employee.  You get 36,000 x $4,000 USD per employee for typical liability costs.....that equates to $144 mm USD in liability costs.
 
 

"In total, substance abuse costs America’s employers more than $160 billion per year in accidents, lost productivity and related problems."

 
When PMED is deployed into all of Hindalco's facilities they will be willing to expense anywhere from $10 mm USD to $20 mm USD for impairment detection to avoid the kind of insane liability costs that come with impairment liability claims & industrial accidents.
 
For 2021 I would use that range.
 
The data (non revenue) is from the company and they did not confirm nor deny the revenue numbers that I used.  They stated it will be a market pleasing sum and it will be self-evident in due course.  Reiterated they will be cash flow positive this year! 
Bullboard Posts